CITADEL ADVISORS LLC: MRNA position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CITADEL ADVISORS LLC on MRNA, newest first. How the timeline and the estimate are built.
CITADEL ADVISORS LLC held 294,496 MRNA shares at 2026-06-30 per its 13F-HR/A filed 2026-09-02.
the latest 13F is the newest step
- period ended2026-06-3013F/A 294,496 sharesChange vs previous 13F -195,274 shares
0.01% of the 13F portfolio, value $20,623,555.
13F-HR/A 0001104659-26-104387 filed by CITADEL ADVISORS LLC
Accepted , ingested - period ended2026-03-3113F 489,770 sharesChange vs previous 13F -89,360 shares
0.02% of the 13F portfolio, value $24,880,316.
13F-HR 0001104659-26-062477 filed by CITADEL ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 579,130 sharesChange vs previous 13F -1,408,601 shares
0.01% of the 13F portfolio, value $17,078,544.
13F-HR 0001104659-26-016408 filed by CITADEL ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 1,987,731 sharesChange vs previous 13F +153,023 shares
0.04% of the 13F portfolio, value $51,343,091.
13F-HR 0001104659-25-112514 filed by CITADEL ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 1,834,708 sharesChange vs previous 13F +74,423 shares
0.04% of the 13F portfolio, value $50,619,594.
13F-HR 0001104659-25-078555 filed by CITADEL ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 1,760,285 sharesChange vs previous 13F +988,393 shares
0.05% of the 13F portfolio, value $49,904,080.
13F-HR 0000950123-25-005687 filed by CITADEL ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 771,892 sharesChange vs previous 13F +519,516 shares
0.03% of the 13F portfolio, value $32,095,269.
13F-HR 0000950123-25-002739 filed by CITADEL ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 252,376 sharesChange vs previous 13F not available
0.02% of the 13F portfolio, value $16,866,288.
13F-HR 0000950123-24-011767 filed by CITADEL ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).